Task: Answer Verification
Input (English): Question: Does a novel aspirin prodrug inhibit NFκB activity and breast cancer stem cell properties?
Answer: These results establish GTCpFE as a prototype for novel ASA-and fumarate-based anti-inflammatory drugs that: (i) are capable of targeting CSCs, and (ii) may be developed as chemopreventive or therapeutic agents in breast cancer.
Output (English): yes